Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication

Chemistry and Biology

Volumn 20, Issue 4, 2013, Pages 570-582

  Nasheri, Neda ^a,b   Joyce, Michael ^c   Rouleau, Yanouchka ^b   Yang, Pengyu ^d   Yao, Shao ^d   Tyrrell, D Lorne ^c   Pezacki, John Paul ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID SYNTHASE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL;

ACTIVITY BASED PROTEIN PROFILING; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGE ANALYSIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO STUDY; MODULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; REPLICON; VIRUS GENOME; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; FATTY ACID SYNTHETASE COMPLEX; GENOTYPE; HEPACIVIRUS; HUMANS; LACTONES; MICE; MICE, SCID; MOLECULAR PROBES; TRIGLYCERIDES; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS; MUS;

EID: 84876461949     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.03.014     Document Type: Article

References (90)

1. J. Adler, and I. Parmryd Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient Cytometry A 77 2010 733 742
2. G. Aragonès, C. Alonso-Villaverde, C. Oliveras-Ferraros, R. Beltrán-Debón, A. Rull, F. Rodríguez-Sanabria, J. Camps, A.V. Martín, J.A. Menéndez, and J. Joven Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection BMC Gastroenterol. 10 2010 92 102
3. A. Ballinger, and S.R. Peikin Orlistat: its current status as an anti-obesity drug Eur. J. Pharmacol. 440 2002 109 117
4. G. Barba, F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M.J. Chapman, T. Miyamura, and C. Bréchot Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets Proc. Natl. Acad. Sci. USA 94 1997 1200 1205
5. K.T. Barglow, and B.F. Cravatt Activity-based protein profiling for the functional annotation of enzymes Nat. Methods 4 2007 822 827
6. M.F. Bassendine, D.A. Sheridan, D.J. Felmlee, S.H. Bridge, G.L. Toms, and R.D. Neely HCV and the hepatic lipid pathway as a potential treatment target J. Hepatol. 55 2011 1428 1440
7. D.R. Blais, M. Brûlotte, Y. Qian, S. Bélanger, S.Q. Yao, and J.P. Pezacki Activity-based proteome profiling of hepatoma cells during hepatitis C virus replication using protease substrate probes J. Proteome Res. 9 2010 912 923
8. D.R. Blais, R.K. Lyn, M.A. Joyce, Y. Rouleau, R. Steenbergen, N. Barsby, L.F. Zhu, A.F. Pegoraro, A. Stolow, D.L. Tyrrell, and J.P. Pezacki Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication J. Biol. Chem. 285 2010 25602 25612
9. D.R. Blais, N. Nasheri, C.S. McKay, M.C. Legault, and J.P. Pezacki Activity-based protein profiling of host-virus interactions Trends Biotechnol. 30 2012 89 99
10. S. Boulant, P. Targett-Adams, and J. McLauchlan Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus J. Gen. Virol. 88 2007 2204 2213
11. E. Bugianesi, F. Salamone, and F. Negro The interaction of metabolic factors with HCV infection: does it matter? J. Hepatol. 56 Suppl 1 2012 S56 S65
12. M.V. Chakravarthy, Z. Pan, Y. Zhu, K. Tordjman, J.G. Schneider, T. Coleman, J. Turk, and C.F. Semenkovich "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis Cell Metab. 1 2005 309 322
13. B.F. Cravatt, A.T. Wright, and J.W. Kozarich Activity-based protein profiling: from enzyme chemistry to proteomic chemistry Annu. Rev. Biochem. 77 2008 383 414
14. L.E. Dietrich, and C. Ungermann On the mechanism of protein palmitoylation EMBO Rep. 5 2004 1053 1057
15. K.W. Dunn, M.M. Kamocka, and J.H. McDonald A practical guide to evaluating colocalization in biological microscopy Am. J. Physiol. Cell Physiol. 300 2011 C723 C742
16. M. Elazar, P. Liu, C.M. Rice, and J.S. Glenn An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication J. Virol. 78 2004 11393 11400
17. M.J. Evans, and B.F. Cravatt Mechanism-based profiling of enzyme families Chem. Rev. 106 2006 3279 3301
18. T. Fujino, M. Nakamuta, R. Yada, Y. Aoyagi, K. Yasutake, M. Kohjima, K. Fukuizumi, T. Yoshimoto, N. Harada, and M. Yada Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver Hepatol. Res. 40 2010 923 929
19. M. Fukasawa, Y. Tanaka, S. Sato, Y. Ono, Y. Nitahara-Kasahara, T. Suzuki, T. Miyamura, K. Hanada, and M. Nishijima Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein Biol. Pharm. Bull. 29 2006 1958 1961
20. M.V. García-Mediavilla, S. Pisonero-Vaquero, E. Lima-Cabello, I. Benedicto, P.L. Majano, F. Jorquera, J. González-Gallego, and S. Sánchez-Campos Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication Lab. Invest. 92 2012 1191 1202
21. M.G. Ghany Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
22. R. Gosert, D. Egger, V. Lohmann, R. Bartenschlager, H.E. Blum, K. Bienz, and D. Moradpour Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons J. Virol. 77 2003 5487 5492
23. J. Gouttenoire, F. Penin, and D. Moradpour Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory Rev. Med. Virol. 20 2010 117 129
24. A. Grakoui, C. Wychowski, C. Lin, S.M. Feinstone, and C.M. Rice Expression and identification of hepatitis C virus polyprotein cleavage products J. Virol. 67 1993 1385 1395
25. D.L. Halvorson, and S.A. McCune Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid Lipids 19 1984 851 856
26. N.S. Heaton, R. Perera, K.L. Berger, S. Khadka, D.J. Lacount, R.J. Kuhn, and G. Randall Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis Proc. Natl. Acad. Sci. USA 107 2010 17345 17350
27. S. Henness, and C.M. Perry Orlistat: a review of its use in the management of obesity Drugs 66 2006 1625 1656
28. E. Herker, and M. Ott Unique ties between hepatitis C virus replication and intracellular lipids Trends Endocrinol. Metab. 22 2011 241 248
29. J.D. Horton, J.L. Goldstein, and M.S. Brown SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 109 2002 1125 1131
30. J.T. Huang, C.P. Tseng, M.H. Liao, S.C. Lu, W.Z. Yeh, N. Sakamoto, C.M. Chen, and J.C. Cheng Hepatitis C virus replication is modulated by the interaction of non-structural protein NS5B and fatty acid synthase J. Virol. 2013 10.1128/JVI.02526-12 Published online February 20, 2013
31. C. Jackel-Cram, L.A. Babiuk, and Q. Liu Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core J. Hepatol. 46 2007 999 1008
32. C. Jackel-Cram, L. Qiao, Z. Xiang, R. Brownlie, Y. Zhou, L. Babiuk, and Q. Liu Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway J. Gen. Virol. 91 2010 1388 1395
33. P. Johansson, B. Mulinacci, C. Koestler, R. Vollrath, D. Oesterhelt, and M. Grininger Multimeric options for the auto-activation of the Saccharomyces cerevisiae FAS type I megasynthase Structure 17 2009 1063 1074
34. J. Joven, E. Espinel, A. Rull, R. Beltrán-Debón, G. Aragonès, E. Rodríguez-Gallego, J. Camps, J. Pedro-Botet, T. Sans, J.A. Menéndez, and C. Alonso-Villaverde Serum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosis J. Clin. Virol. 51 2011 199 201
35. S.B. Kapadia, and F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc. Natl. Acad. Sci. USA 102 2005 2561 2566
36. K.H. Kim, S.P. Hong, K. Kim, M.J. Park, K.J. Kim, and J. Cheong HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma Biochem. Biophys. Res. Commun. 355 2007 883 888
37. L.M. Knowles, F. Axelrod, C.D. Browne, and J.W. Smith A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2 J. Biol. Chem. 279 2004 30540 30545
38. H. Lerat, H.L. Kammoun, I. Hainault, E. Mérour, M.R. Higgs, C. Callens, S.M. Lemon, F. Foufelle, and J.M. Pawlotsky Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice J. Biol. Chem. 284 2009 33466 33474
39. W. Li, J.L. Blankman, and B.F. Cravatt A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases J. Am. Chem. Soc. 129 2007 9594 9595
40. Q. Li, A.L. Brass, A. Ng, Z. Hu, R.J. Xavier, T.J. Liang, and S.J. Elledge A genome-wide genetic screen for host factors required for hepatitis C virus propagation Proc. Natl. Acad. Sci. USA 106 2009 16410 16415
41. J.M. Liefhebber, B.W. Brandt, R. Broer, W.J. Spaan, and H.C. van Leeuwen Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain Virol. J. 6 2009 62
42. L.L. Listenberger, X. Han, S.E. Lewis, S. Cases, R.V. Farese Jr., D.S. Ory, and J.E. Schaffer Triglyceride accumulation protects against fatty acid-induced lipotoxicity Proc. Natl. Acad. Sci. USA 100 2003 3077 3082
43. R.K. Lyn, D.C. Kennedy, A. Stolow, A. Ridsdale, and J.P. Pezacki Dynamics of lipid droplets induced by the hepatitis C virus core protein Biochem. Biophys. Res. Commun. 399 2010 518 524
44. N. Majeau, R. Fromentin, C. Savard, M. Duval, M.J. Tremblay, and D. Leclerc Palmitoylation of hepatitis C virus core protein is important for virion production J. Biol. Chem. 284 2009 33915 33925
45. E.M.M. Manders, F.J. Verbeek, and J.A. Aten Measurement of co-localization of objects in dual-colour confocal images J. Microsc. 169 1993 375 382
46. A.B. Marnett, A.M. Nomura, N. Shimba, P.R. Ortiz de Montellano, and C.S. Craik Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor Proc. Natl. Acad. Sci. USA 101 2004 6870 6875
47. M.A. Martín-Acebes, A.B. Blázquez, N. Jiménez de Oya, E. Escribano-Romero, and J.-C. Saiz West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids PLoS ONE 6 2011 e24970
48. B.R. Martin, C. Wang, A. Adibekian, S.E. Tully, and B.F. Cravatt Global profiling of dynamic protein palmitoylation Nat. Methods 9 2011 84 89
49. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 7 2007 763 777
50. J.A. Menendez, A. Vazquez-Martin, F.J. Ortega, and J.M. Fernandez-Real Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer Clin. Chem. 55 2009 425 438
51. D.F. Mercer, D.E. Schiller, J.F. Elliott, D.N. Douglas, C. Hao, A. Rinfret, W.R. Addison, K.P. Fischer, T.A. Churchill, and J.R. Lakey Hepatitis C virus replication in mice with chimeric human livers Nat. Med. 7 2001 927 933
52. S. Mirandola, S. Realdon, J. Iqbal, M. Gerotto, F. Dal Pero, G. Bortoletto, M. Marcolongo, A. Vario, C. Datz, M.M. Hussain, and A. Alberti Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis Gastroenterology 130 2006 1661 1669
53. Y. Miyanari, K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, and K. Shimotohno The lipid droplet is an important organelle for hepatitis C virus production Nat. Cell Biol. 9 2007 1089 1097
54. M. Moche, G. Schneider, P. Edwards, K. Dehesh, and Y. Lindqvist Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase J. Biol. Chem. 274 1999 6031 6034
55. P.L. Nguyen, J. Ma, J.E. Chavarro, M.L. Freedman, R. Lis, G. Fedele, C. Fiore, W. Qiu, M. Fiorentino, and S. Finn Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival J. Clin. Oncol. 28 2010 3958 3964
56. J.-K. Oem, C. Jackel-Cram, Y.-P. Li, Y. Zhou, J. Zhong, H. Shimano, L.A. Babiuk, and Q. Liu Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2 J. Gen. Virol. 89 2008 1225 1230
57. H. Ovaa, B.M. Kessler, U. Rolén, P.J. Galardy, H.L. Ploegh, and M.G. Masucci Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells Proc. Natl. Acad. Sci. USA 101 2004 2253 2258
58. D. Pacheco-Alvarez, R.S. Solórzano-Vargas, R.A. Gravel, R. Cervantes-Roldán, A. Velázquez, and A. León-Del-Río Paradoxical regulation of biotin utilization in brain and liver and implications for inherited multiple carboxylase deficiency J. Biol. Chem. 279 2004 52312 52318
59. R.S. Padwal, and S.R. Majumdar Drug treatments for obesity: orlistat, sibutramine, and rimonabant Lancet 369 2007 71 77
60. G. Pappenberger, J. Benz, B. Gsell, M. Hennig, A. Ruf, M. Stihle, R. Thoma, and M.G. Rudolph Structure of the human fatty acid synthase KS-MAT didomain as a framework for inhibitor design J. Mol. Biol. 397 2010 508 519
61. C.-Y. Park, H.-J. Jun, T. Wakita, J.H. Cheong, and S.B. Hwang Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway J. Biol. Chem. 284 2009 9237 9246
62. C.W. Pemble 4th, L.C. Johnson, S.J. Kridel, and W.T. Lowther Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat Nat. Struct. Mol. Biol. 14 2007 704 709
63. R. Perera, C. Riley, G. Isaac, A.S. Hopf-Jannasch, R.J. Moore, K.W. Weitz, L. Pasa-Tolic, T.O. Metz, J. Adamec, and R.J. Kuhn Dengue virus infection perturbs lipid homeostasis in infected mosquito cells PLoS Pathog. 8 2012 e1002584
64. G. Perlemuter, A. Sabile, P. Letteron, G. Vona, A. Topilco, Y. Chrétien, K. Koike, D. Pessayre, J. Chapman, G. Barba, and C. Bréchot Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis FASEB J. 16 2002 185 194
65. J.P. Pezacki, R. Singaravelu, and R.K. Lyn Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem Mol. Biosyst. 6 2010 1131 1142
66. R.D. Richardson, G. Ma, Y. Oyola, M. Zancanella, L.M. Knowles, P. Cieplak, D. Romo, and J.W. Smith Synthesis of novel beta-lactone inhibitors of fatty acid synthase J. Med. Chem. 51 2008 5285 5296
67. U. Rolén, V. Kobzeva, N. Gasparjan, H. Ovaa, G. Winberg, F. Kisseljov, and M.G. Masucci Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines Mol. Carcinog. 45 2006 260 269
68. S.M. Sagan, Y. Rouleau, C. Leggiadro, L. Supekova, P.G. Schultz, A.I. Su, and J.P. Pezacki The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication Biochem. Cell Biol. 84 2006 67 79
69. E. Schweizer, and J. Hofmann Microbial type I fatty acid synthases (FAS): major players in a network of cellular FAS systems Microbiol. Mol. Biol. Rev. 68 2004 501 517
70. C.F. Semenkovich Regulation of fatty acid synthase (FAS) Prog. Lipid Res. 36 1997 43 53
71. M.Y. Sheikh, J. Choi, I. Qadri, J.E. Friedman, and A.J. Sanyal Hepatitis C virus infection: molecular pathways to metabolic syndrome Hepatology 47 2008 2127 2133
72. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect. Dis. 5 2005 558 567
73. R. Singaravelu, D.R. Blais, C.S. McKay, and J.P. Pezacki Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe Proteome Sci. 8 2010 5
74. A. Street, A. Macdonald, C. McCormick, and M. Harris Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription J. Virol. 79 2005 5006 5016
75. A.I. Su, J.P. Pezacki, L. Wodicka, A.D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R.H. Purcell, P.G. Schultz, and F.V. Chisari Genomic analysis of the host response to hepatitis C virus infection Proc. Natl. Acad. Sci. USA 99 2002 15669 15674
76. G.H. Syed, Y. Amako, and A. Siddiqui Hepatitis C virus hijacks host lipid metabolism Trends Endocrinol. Metab. 21 2010 33 40
77. A.W. Tai, Y. Benita, L.F. Peng, S.S. Kim, N. Sakamoto, R.J. Xavier, and R.T. Chung A functional genomic screen identifies cellular cofactors of hepatitis C virus replication Cell Host Microbe 5 2009 298 307
78. K. Tsuboi, D.A. Bachovchin, A.E. Speers, S.J. Brown, T. Spicer, V. Fernandez-Vega, J. Ferguson, B.F. Cravatt, P. Hodder, and H. Rosen Optimization and Characterization of an Inhibitor for Glutathione S-Tranferase Omega 1 (GSTO1). Probe Reports from the NIH Molecular Libraries Program 2010 National Center for Biotechnology Information Bethesda, MD
79. F.H. Vaillancourt, M. Brault, L. Pilote, N. Uyttersprot, E.T. Gaillard, J.H. Stoltz, B.L. Knight, L. Pantages, M. McFarland, and S. Breitfelder Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target J. Virol. 86 2012 11595 11607
80. S.J. Wakil Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 28 1989 4523 4530
81. K.A. Walters, M.A. Joyce, J.C. Thompson, M.W. Smith, M.M. Yeh, S. Proll, L.F. Zhu, T.J. Gao, N.M. Kneteman, D.L. Tyrrell, and M.G. Katze Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response PLoS Pathog. 2 2006 e59
82. G. Waris, D.J. Felmlee, F. Negro, and A. Siddiqui Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress J. Virol. 81 2007 8122 8130
83. Z. Xiang, L. Qiao, Y. Zhou, L.A. Babiuk, and Q. Liu Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1 Biochem. Biophys. Res. Commun. 402 2010 549 553
84. W. Yang, B.L. Hood, S.L. Chadwick, S. Liu, S.C. Watkins, G. Luo, T.P. Conrads, and T. Wang Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production Hepatology 48 2008 1396 1403
85. P.Y. Yang, K. Liu, M.H. Ngai, M.J. Lear, M.R. Wenk, and S.Q. Yao Activity-based proteome profiling of potential cellular targets of Orlistat - an FDA-approved drug with anti-tumor activities J. Am. Chem. Soc. 132 2010 656 666
86. P.Y. Yang, K. Liu, C. Zhang, G.Y. Chen, Y. Shen, M.H. Ngai, M.J. Lear, and S.Q. Yao Chemical modification and organelle-specific localization of orlistat-like natural-product-based probes Chem. Asian J. 6 2011 2762 2775
87. P.Y. Yang, M. Wang, K. Liu, M.H. Ngai, O. Sheriff, M.J. Lear, S.K. Sze, C.Y. He, and S.Q. Yao Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent Chemistry 18 2012 8403 8413
88. G.Y. Yu, K.J. Lee, L. Gao, and M.M. Lai Palmitoylation and polymerization of hepatitis C virus NS4B protein J. Virol. 80 2006 6013 6023
89. W. Zhang, B. Chakravarty, F. Zheng, Z. Gu, H. Wu, J. Mao, S.J. Wakil, and F.A. Quiocho Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid Proc. Natl. Acad. Sci. USA 108 2011 15757 15762
90. V. Zinchuk, and O. Grossenbacher-Zinchuk Quantitative colocalization analysis of confocal fluorescence microscopy images Curr. Protoc. Cell Biol. 52 2011 4.19.1 4.19.16